LENZ Therapeutics, Inc. (LENZ) Shares Outstanding (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Shares Outstanding for 2 consecutive years, with $58.0 million as the latest value for Q3 2023.
- On a quarterly basis, Shares Outstanding changed 0.31% to $58.0 million in Q3 2023 year-over-year; TTM through Sep 2023 was $58.0 million, a 0.31% change, with the full-year FY2022 number at $58.2 million, changed N/A from a year prior.
- Shares Outstanding was $58.0 million for Q3 2023 at LENZ Therapeutics, roughly flat from $58.0 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $58.2 million in Q4 2022 to a low of $58.0 million in Q3 2023.